Figure 1From: Dexmedetomidine versus standard care sedation with propofol or midazolam in intensive care: an economic evaluation The likelihood of dexmedetomidine (D) to result in lower total intensive care unit costs than pooled standard care sedatives (SC), assessed by bootstrapping. As indicated by the black circle, the likelihood that dexmedetomidine results in lower total intensive care unit costs than the standard sedatives is 91.0%.Back to article page